{"cdcTestId":"2018-0003","testcaseName":"Zoster: Dose #2 (Shingrix) administered at 4 weeks after dose #1","vaccineGroup":"ZOSTER","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1972-09-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2018-03-27T20:00:00","dateUpdated":"2018-04-19T13:54:24.956","generalDescription":"This test case describes when a patient is administered dose #2 of the RZV vaccine 4 weeks after the first dose that the series is considered complete.","changedInVersion":"3.4","reasonForChange":""}